Cargando…
Should we undertake surveillance for HCC in patients with MAFLD?
Over the last decade, metabolic-associated fatty liver disease (MAFLD) has become an important public health issue worldwide. In many countries, MAFLD has become the most common cause of chronic liver disease. On the contrary, hepatocellular carcinoma (HCC) mortality is rising. Liver tumors have bec...
Autores principales: | Norero, Blanca, Dufour, Jean-François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052487/ https://www.ncbi.nlm.nih.gov/pubmed/37006779 http://dx.doi.org/10.1177/20420188231160389 |
Ejemplares similares
-
MAFLD: a multisystem disease
por: Pipitone, Rosaria Maria, et al.
Publicado: (2023) -
Screening for MAFLD: who, when and how?
por: Pal, Shreya C., et al.
Publicado: (2023) -
Emerging pharmacological treatment options for MAFLD
por: Rojas, Ángela, et al.
Publicado: (2022) -
Non-pharmacological management options for MAFLD: a practical
guide
por: Stefano, José Tadeu, et al.
Publicado: (2023) -
The bidirectional impacts of alcohol consumption and MAFLD for progressive fatty liver disease
por: Kulkarni, Anand V., et al.
Publicado: (2023)